Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults With Schizophrenia, Schizophreniform, or Bipolar I Disorder Who Are Early in Their Illness

Next Previous
X
Search
Trial Profile

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults With Schizophrenia, Schizophreniform, or Bipolar I Disorder Who Are Early in Their Illness

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olanzapine/samidorphan (Primary) ; Olanzapine
  • Indications Bipolar I disorders; Psychotic disorders; Schizophrenia
  • Focus Registrational; Therapeutic Use
  • Acronyms ENLIGHTEN-Early
  • Sponsors Alkermes plc

    • Most Recent Events

    • 11 Sep 2023 According to a Alkermes media release, results of meta-analysis using individual subject-level data from this trial presented at the 36th Annual Psych Congress (Psych Congress), which took place Sept. 6-10, 2023 in Nashville.
    • 23 Mar 2023 Results published in an Alkermes Media Release.
    • 23 Mar 2023 According to an Alkermes media release, results from this trial were published in the peer-reviewed publication, the Journal of Clinical Psychiatry.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top